Literature DB >> 12516566

Different profile of CD8+ effector T cells induced in Der p 1-allergic and naïve mice by DNA vaccination.

Monia Draghi1, Elizabeth R Jarman, Renata Grifantini, Luisa Galli-Stampino, Jonathan R Lamb, Nicholas M Valiante, Guido Grandi.   

Abstract

DNA vaccination holds great promise in both prophylactic and therapeutic vaccines. Recent evidence suggests that DNA vaccines could be powerful therapies countering Th2-mediated disorders such as allergies. Here, we studied the allergen-specific CD4+ and CD8+ T cell populations induced following immunization of allergic and non-allergic mice with DNA vaccine vectors encoding discrete epitopes of the house dust mite (HDM) Dermatophagoides pteronyssinus group I (Der p 1) allergen. Specifically, mice were sensitized to Der p 1 and exhibited a strong Th2/allergic response. Sensitized and non-allergic mice were then compared for their responses to DNA immunization. Using Elispot analysis, we demonstrate that allergic/vaccinated mice generate a mixed Th1/Th2 response against the allergen with high numbers of allergen-specific CD4+ T cells secreting IFN-gamma or IL-4, whereas in non-allergic/vaccinated mice a polarized Th1 response was dominant. Allergen-specific CD8+ T cells secreting IFN-gamma were induced at equal frequencies in both allergic and non-allergic mice. However, the CD8+ T cells from allergic mice were markedly deficient in their cytotoxic potential when compared to their counterparts in non-allergic mice. These results indicate that during an ongoing Th2 response, DNA vaccination leads to the generation of a distinct population of non-cytotoxic/regulatory CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12516566     DOI: 10.1002/1521-4141(200212)32:12<3720::AID-IMMU3720>3.0.CO;2-J

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Blomia tropicalis allergen 5 (Blo t 5) T-cell epitopes and their ability to suppress the allergic immune response.

Authors:  Kenneth H Wong; Qian Zhou; Nayana Prabhu; Kazuki Furuhashi; Yen Leong Chua; Gijsbert M Grotenbreg; David M Kemeny
Journal:  Immunology       Date:  2017-07-17       Impact factor: 7.397

2.  Reversal of established CD4+ type 2 T helper-mediated allergic airway inflammation and eosinophilia by therapeutic treatment with DNA vaccines limits progression towards chronic inflammation and remodelling.

Authors:  Elizabeth R Jarman; Jonathan R Lamb
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

3.  Biased Generation and In Situ Activation of Lung Tissue-Resident Memory CD4 T Cells in the Pathogenesis of Allergic Asthma.

Authors:  Damian L Turner; Monica Goldklang; Filip Cvetkovski; Daniel Paik; Jordis Trischler; Josselyn Barahona; Minwei Cao; Ronak Dave; Nicole Tanna; Jeanine M D'Armiento; Donna L Farber
Journal:  J Immunol       Date:  2018-01-17       Impact factor: 5.422

4.  Protective effect of the DNA vaccine encoding the major house dust mite allergens on allergic inflammation in the murine model of house dust mite allergy.

Authors:  Nacksung Kim; Soon Seog Kwon; Jaechun Lee; Sohyung Kim; Tai June Yoo
Journal:  Clin Mol Allergy       Date:  2006-02-20

Review 5.  DNA and mRNA vaccination against allergies.

Authors:  Sandra Scheiblhofer; Josef Thalhamer; Richard Weiss
Journal:  Pediatr Allergy Immunol       Date:  2018-09-20       Impact factor: 6.377

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.